Subcutaneous injection of factor IX for the treatment of haemophilia B
- 1 August 1992
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 81 (4) , 610-613
- https://doi.org/10.1111/j.1365-2141.1992.tb03001.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Electrically erodible polymer gel for controlled release of drugsNature, 1991
- Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusionThe Lancet, 1991
- Clinical Pharmacokinetics of Epoetin (Recombinant Human Erythropoietin)Clinical Pharmacokinetics, 1991
- Clinical Pharmacokinetics of InterferonsClinical Pharmacokinetics, 1990
- Effect of Molecular Weight on the Lymphatic Absorption of Water-Soluble Compounds Following Subcutaneous AdministrationPharmaceutical Research, 1990
- Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia BBlood, 1989
- An alternative approach to somatic cell gene therapy.Proceedings of the National Academy of Sciences, 1988
- Expression of active human clotting factor IX from recombinant DNA clones in mammalian cellsNature, 1985
- The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these FactorsBritish Journal of Haematology, 1963
- Coagulation properties of canine thoracic-duct lymphAmerican Journal of Physiology-Legacy Content, 1960